Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) cleaves amyloid-β protein precursor (AβPP).
• BACE1 is a therapeutic target for Alzheimer's disease (AD).
• BACE1 inhibition causes neurodevelopmental issues, but its effect on mature neurons is unknown.

Purpose of the Study:

• To investigate the long-term effects of BACE1 inhibition on neuronal circuits and synapses in developed neurons.
• To determine if BACE1's synaptic function is stage-dependent.

Main Methods:

• Utilized hippocampal slice cultures as an ex vivo model for long-term analysis.
• Analyzed temporal changes in synaptic proteins following BACE1 inhibition.

Main Results:

• Long-term BACE1 inhibition during neurodevelopment caused synaptic protein loss.
• BACE1 inhibition did not alter synaptic proteins in the mature, developed stage.
• Synaptic protein levels showed phases of loss, formation, and maintenance.

Conclusions:

• BACE1's function on synapses is dependent on the developmental stage.
• Hippocampal slice cultures provide a model for studying long-term BACE1 effects and inhibitor side effects.
• BACE1 inhibitors may have different impacts depending on the patient's neurodevelopmental stage.